Clinical Study
Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
Table 1
Demographic and preoperative data of patients diagnosed with intermediate uveitis.
| Parameters | |
| Number | 66 patients, 66 eyes | Age | 48.76 ± 13.51 (min: 21, max: 75) | Gender (male : female) | 40 : 26 | Laterality (right : left) | 39 : 27 | Bilateral intermediate uveitis | 13/66 (19.7%) | Preoperative best-corrected visual acuity (BCVA) | 0.81 ± 0.64 | Period from onset of uveitis to vitrectomy (months) | 32.63 ± 40.95 (min: 3, max: 290) | Lens state | | Phakia/pseudophakia | 59/7 | Operation indications | | Epiretinal membrane | 26/66 (39.4%) | Vitreous opacity | 21/66 (31.8%) | Tractional retinal detachment | 12/66 (18.2%) | Macular edema | 5/66 (7.6%) | Vitreous hemorrhage | 2/66 (3.0%) | Total | 66 | Postoperative follow-up period (months) | 48.91 ± 40.38 (min: 12, max: 180) | BCVA at final follow-up | 0.41 ± 0.50 |
|
|
BCVA: best-corrected visual acuity; BCVA was converted to the logarithm of the minimal angle of resolution.
|